In his published letter to the editor in the Financial Times, Dr. Andrew Rut, CEO of MyMeds&Me responds to a recent FT report, “Patients take control of their medical data” contending that wearable data should be tested for accuracy, if it is to have any purpose in the medical and pharmaceutical world.
Read the letter online here, or available in the Monday 29 April edition of the Financial Times newspaper.
